These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3994900)

  • 1. A comparison of standard and sustained release clonidine with respect to plasma concentration and blood pressure changes.
    Shaffer JL; Pleuvry BJ; Davies DS; Murray S
    Br J Clin Pharmacol; 1985 Apr; 19(4):524-6. PubMed ID: 3994900
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in sleep pattern, blood pressure, heart rate and plasma noradrenaline after night-time administration of slow release clonidine [proceedings].
    Dollery CT; Hamilton CA; Maling TJ
    Br J Clin Pharmacol; 1977 Oct; 4(5):634P. PubMed ID: 911619
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of sustained-release and standard preparations of clonidine in essential hypertension.
    Fyhrquist F
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):634-6. PubMed ID: 6365808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clinical study on the prolonged antihypertensive effect of clonidine in a sustained-release capsule formulation.
    Martens V; Bentsen P; Hochrein H
    Pharmatherapeutica; 1980; 2(7):456-61. PubMed ID: 7208540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of low clonidine doses in galenic sustained-release preparations. Study with Combipresan 75 perlongettes].
    Bibracher C; Podzich M
    MMW Munch Med Wochenschr; 1982 May; 124(18):457-8. PubMed ID: 6808370
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability and clinical effects of three brands of clonidine: the relationship between plasma level and effect.
    Kanto J; Allonen H; Hiltunen R; Marvola M; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):118-21. PubMed ID: 7068284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacological studies with clonidine in normal subjects.
    Davies DS; Wing LM; Reid JL; Tippett P; Dollery CT
    Clin Sci Mol Med Suppl; 1976 Dec; 3():639s-640s. PubMed ID: 1071696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steady state plasma concentration of clonidine and its relation to the effects on blood pressure in normotensive and hypertensive rats.
    Christersson S; Frisk-Holmberg M; Paalzow L
    J Pharm Pharmacol; 1979 Jun; 31(6):418-9. PubMed ID: 39150
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between osmotic mini-pumps and controlled release pellets in chronic clonidine administration in the spontaneously hypertensive rat.
    Hess RW; Hardman SL; Shirachi DY; Taubert KA
    Proc West Pharmacol Soc; 1985; 28():97-101. PubMed ID: 4070269
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of clonidine in human plasma by cold on-column injection capillary gas chromatography-selected-ion monitoring-mass spectrometry.
    Arrendale RF; Stewart JT; Tackett RL
    J Chromatogr; 1988 Nov; 432():165-75. PubMed ID: 3220886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma clonidine levels in hypertension.
    Velasquez MT; Rho J; Maronde RF; Barr J
    Clin Pharmacol Ther; 1983 Sep; 34(3):341-6. PubMed ID: 6883910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antihypertensive effects of a new transdermal delivery system for clonidine (M-5041T) in spontaneously hypertensive rats.
    Ishii R; Naruse T; Tagawa T; Yamahata T; Dote S; Hamada K; Ishida T; Funabiki K; Namba K
    Arch Int Pharmacodyn Ther; 1994; 327(3):294-308. PubMed ID: 7848013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The central hypotensive effect of clonidine. Studies in tetraplegic subjects.
    Reid JL; Wing LM; Mathias CJ; Frankel HL; Neill E
    Clin Pharmacol Ther; 1977 Apr; 21(4):375-81. PubMed ID: 321174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the antihypertensive action of normal clonidine and delayed-preparation clonidine].
    Ambrosioni E; Caldari R; Costa FV; Magnani B
    G Clin Med; 1979 Jul; 60(7):569-82. PubMed ID: 548293
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of clonidine and its relation to the hypotensive effect in patients.
    Frisk-Holmberg M; Edlund PO; Paalzow L
    Br J Clin Pharmacol; 1978 Sep; 6(3):227-32. PubMed ID: 687501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of an effect of age on the response to clonidine.
    Klein CE; Gerber JG; Nies AS
    Clin Pharmacol Ther; 1990 Jan; 47(1):61-7. PubMed ID: 2153063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology and pharmacokinetics of clonidine.
    Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
    Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent resistance to hypotensive effect of clonidine.
    Wing LM; Reid JL; Davies DS; Dargie HJ; Dollery CT
    Br Med J; 1977 Jan; 1(6054):136-8. PubMed ID: 832037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose.
    Klein C; Morton N; Kelley S; Metz S
    J Hypertens Suppl; 1985 Dec; 3(4):S81-4. PubMed ID: 3868715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term administration of clonidine on plasma renin activity.
    De Wurstemberger B; Gysling E
    Can Med Assoc J; 1976 Dec; 115(11):1107-8. PubMed ID: 1000443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.